Task: Answer Verification
Input (English): Question: Do nAT1 genotypes predict response to mesalamine in patients with ulcerative colitis?
Answer: NAT1 genotypes do not predict response or side effects to mesalamine in patients with UC. Variations caused by non-genomic effects may be associated with the clinical response to 5-ASA.
Output (English): no